Joltoo
InvestorsInsights
DeepTech 2026 Playbook
Browse all
  1. Home
  2. /Investors
  3. /Biotech
  4. /Avalon BioVentures
Avalon BioVentures

Avalon BioVentures

DeepTech NativeLa Jolla, United StatesActiveWebsite
Stage FocusPre-Seed, Seed
GeographyUS
TypeVC
Last Activity2024
Industry Focus
Industries
BiotechMedTech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio

Avalon BioVentures has been driving life sciences innovation from San Diego for over 40 years, managing a $135M fund exclusively for early-stage biotech startups. The exits tell the story: $4B+ generated across investments including Aratana (IPO), Synthorx (acquired by Sanofi), Janux (IPO), and Nerio (acquired by Boehringer Ingelheim for $1.3B). Across the broader Avalon Ventures platform, there h...

Notable Investments
J
Janux Therapeutics
A
Aratana Therapeutics
S
Synthorx
N
Nerio Therapeutics

Similar Funds

BioGenerator

BioGenerator

St. Louis, United States

DeepTech NativeBiotechAgriTechMedTechPre-SeedSeed
Amino Collective

Amino Collective

Berlin, Germany

DeepTech NativeBiotechSynthetic BiologyMedTechPre-SeedSeed
Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

Ingelheim am Rhein, Germany

GeneralistBiotechMedTechPre-SeedSeed
Longwood Fund

Longwood Fund

Boston, United States

Pure DeepTechBiotechMedTechPre-SeedSeed
Nordic Science Investments

Nordic Science Investments

Helsinki, Finland

DeepTech NativeBiotechMedTechAI InfrastructurePre-SeedSeed
SciFounders

SciFounders

San Francisco, United States

DeepTech NativeBiotechSynthetic BiologyPre-SeedSeed
Joltoo
Privacy PolicyTerms of Service
© 2026 Joltoo. All rights reserved.